Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Express Scripts
AstraZeneca
Chinese Patent Office
Deloitte
Chubb
Julphar
Argus Health

Generated: September 20, 2018

DrugPatentWatch Database Preview

Neopharma Company Profile

« Back to Dashboard

What is the competitive landscape for NEOPHARMA, and what generic and branded alternatives to NEOPHARMA drugs are available?

NEOPHARMA has five approved drugs.



Summary for Neopharma
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Neopharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Neopharma PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078383-002 Mar 12, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Neopharma IRBESARTAN irbesartan TABLET;ORAL 203161-003 Sep 27, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Neopharma PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078383-001 Mar 12, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Neopharma ALENDRONATE SODIUM alendronate sodium TABLET;ORAL 079049-001 Aug 4, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Neopharma IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 078953-002 Apr 15, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Neopharma ALENDRONATE SODIUM alendronate sodium TABLET;ORAL 079049-004 Aug 4, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Teva
Citi
Medtronic
McKesson
UBS
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.